Surims Ltd Logo
 
 
 
 
 
 
Oramed Logo  
 
 
Basic Profile
 
If you'd like to claim this company profile for Oramed, please Contact Us.
 

Oramed News

The latest news, announcements and press releases from Oramed.

 
 
01
April
2021
01st April 2021
 

Premas, Oramed unite to found oral COVID-19 vaccine startup

 




    • Good candidate for protection against COVID variants due to triple antigen targeting 



 




    • Implications for potential ease of widescale distribution and administration anytime, anywhere for oral COVID-19 vaccine 



 




    • Efficacy following a single oral dose administration in preclinical study 



 




    • Clinical trial expected to commence Q2 2021 



 




    • Watch video 



 




    • Successful expansion of Oramed’s POD oral delivery technology into the lucrative vaccine development market



 

 
Read the full story »
 
 
10
July
2015
10th July 2015
 

SINOPHARM CAPITAL-HEFEI SIGNS LETTER OF INTENT WITH ORAMED FOR $50,000,000 INVESTMENT AND LICENSING DEAL IN CHINA

JERUSALEM, July 7, 2015

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has signed a non-binding Letter of Intent (LoI) for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science & Technology Park Investments and Development Co., Ltd. (Sinopharm/Hefei) potentially valued at $50,000,000 plus royalty payments. Oramed will receive $500,000 in exchange for exclusively negotiating with Sinopharm/Hefei for 60 days, while the final terms of the agreement are negotiated and finalized.
 
Read the full story »
 
 
 

Claim This Profile

This is the News section of the company profile page for Oramed on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

 
 
Oramed company details, activities, contacts and reviews.
 
Oramed partnership and licensing opportunities.
 
Oramed latest news, announcements and press releases.
 
Oramed documents, images and videos.
 
Oramed global factories, offices and locations.
 
Oramed legal and financial information.
 
 
 
 
 
 
 

About Us

Surims Ltd is a consultancy established in 2003 supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at https://www.surims.com.

 
 
 

Get in Touch

The Pharmaceutical Services Directory
info@pharmaservicesdirectory.com

 
 

© 2021 Surims Ltd | All Rights Reserved.